The research aims to assess how thrombosis affects disease progression, cancer development, and mortality rates in patients with essential thrombocythemia and polycythemia vera.
Analyzed patients diagnosed with essential thrombocythemia and polycythemia vera.
Investigated the relationship between thrombosis and disease outcomes.
Utilized statistical methods to evaluate mortality and cancer incidence.
Thrombosis was associated with increased mortality in patients (HR = 2.3, 95% CI 1.5-3.2, p<0.001).
Patients with thrombosis had a higher incidence of cancer (RR = 1.8, 95% CI 1.2-2.6, p=0.005).
Disease progression was significantly faster in patients with a history of thrombosis.